Back to CBRS Asset Hub
CBRS ALERT
+11.77% Snapshot Move
Last 23 Hours
7 Cited Sources

Cerebras' Margin Scare Was a Misread — and the Street Is Repricing CBRS

CBRS is up about 12% over the past day to roughly $191, extending a rebound off last week's post-earnings low near $161. The slide came from a soft gross-margin guide that CEO Andrew Feldman says investors misread — the lighter margins reflect a temporary decision to rent back its own systems to deploy capacity faster, not structural pricing pressure. Morgan Stanley, Wedbush and Mizuho have all lifted targets into the $273–$300 range since earnings, and OpenAI's GPT-5.6 Sol is set to run on Cerebras silicon at up to 750 tokens per second in July. The market is treating the dip as an overshoot.

CBRS Asset HubSnapshot Preserved Original Tweet
Publish-time Hyperliquid price chart for CBRS, showing a recorded +11.77% move over 23h.

Mover Brief

Why the Margin Scare Was a Misread

CBRS didn't fall because the business is broken — it fell because the first earnings report as a public company landed an EPS miss alongside soft margin guidance. The quarter itself was strong: core revenue of $191.3 million, up about 92% year over year, with the net loss narrowing to $14 million from $23.9 million a year earlier. What spooked the tape was the full-year gross-margin guide of 38–41% against the 47% Cerebras printed in Q1, with Q2 guided to just 36–38%. Shares sold off roughly 17%.

CEO Andrew Feldman pushed back the next day, saying investors had misunderstood the guidance. His explanation: the lighter near-term margin comes from a temporary decision to rent its own systems back from a customer to bring capacity online faster — a deployment-speed choice, not structural pricing pressure. If he's right, the 38–41% guide is a floor distorted by a one-off, not a new baseline. The market spent the back half of the week deciding he's probably right.

The Street Reprices the Dip

The sell-side didn't blink. Morgan Stanley lifted its target to $273 from $250 and kept an Overweight, calling it a strong debut quarter with top-line and gross-margin upside — and noting the margin outlook still sits well above its own ~24% estimate. Wedbush went to $280 from $270 with an Outperform. Mizuho reiterated Outperform with a $300 target, and its note carried the detail that actually matters for the bull case: cloud revenue up about 60% quarter over quarter on the OpenAI ramp, with Cerebras pulling roughly 50% higher pricing on incremental fast-inference demand.

That pricing line is the tell. The bear thesis is margin compression; the data says Cerebras has pricing power on exactly the inference workloads that are scaling fastest. With three desks clustered at $273–$300 against a stock near $191, the gap between price and target is doing a lot of the work in this bounce.

GPT-5.6 Sol Puts a Date on the $20B Deal

Underneath the bounce is the fact that the $20 billion OpenAI deal — a multi-year, 750-megawatt compute commitment running in tranches through 2028 — is turning into a shippable product. OpenAI's new flagship, GPT-5.6 Sol, is set to go live on Cerebras silicon in July at up to 750 tokens per second. That converts an abstract backlog number into a dated, benchmarkable launch — the kind of thing a market can actually price.

There's a wrinkle: Sol's initial access is restricted to select partners through the API and Codex at the direction of the US government, a policy OpenAI publicly calls unsustainable. Demand isn't the constraint here; distribution is. For Cerebras the relevant fact is simpler — its hardware is the inference layer for OpenAI's fastest model, and OpenAI is enough of a counterparty that it also extended Cerebras a $1 billion working-capital loan now sitting on the balance sheet.

What Could Still Break It

The margin debate isn't settled by a CEO soundbite. Q2 core gross margin is still guided to 36–38%, and if the rent-back drag persists past a quarter or two, the bears get their structural-compression story back. Sol's government-gated rollout could slip, and a model that can't reach developers doesn't pull through inference volume on schedule. And this is a name that only IPO'd in May — the debut popped 68% to a roughly $95 billion cap — so it still trades with post-IPO volatility and an eventual lockup overhang. On the perp specifically, the ~$22.5 million of 24h volume on this market is thin relative to the underlying equity, so basis to spot can gap around weekend and after-hours moves.

Sources & Provenance

Citations below are preserved as structured Postgres source rows for this brief.

Citations Preserved

7

Reference links carried forward from the published mover record.

Original Signal

Open source tweet

Market Route

Direct route preserved for readers who want to inspect the tracked Hyperliquid market behind this archive entry.

Already onboarded? Open tracked market
  1. 1Cerebras Systems Q1 2026 results (company release)investors.cerebras.ai
  2. 2CNBC: Cerebras Q1 earnings reportcnbc.com
  3. 3CNBC: Feldman says margin outlook was 'misunderstood'cnbc.com
  4. 4The Decoder: GPT-5.6 Sol to run on Cerebras at up to 750 tokens/secthe-decoder.com
  5. 5Investing.com: Mizuho reiterates Outperform on OpenAI rampinvesting.com
  6. 6TheStreet: Morgan Stanley's Cerebras price targetthestreet.com
  7. 7CNBC: Cerebras Nasdaq debutcnbc.com

This content is for informational purposes only and does not constitute financial advice. Trading perpetual futures involves substantial risk of loss.

Trade CBRS on Hyperliquid

Use referral code HIPERWIRE for 4% off trading fees on your first $25M in volume.

Live Market Metrics

Monitor real-time open interest and funding for CBRS.

Open CBRS In Terminal Screener